MRNA vs ROIV
Moderna, Inc. · Roivant Sciences Ltd.
Relative return (rebased to 100)
Key stats
| Metric | MRNA | ROIV |
|---|---|---|
| Price | $226.30 | $33.62 |
| Market Cap | $90.35B | $24.28B |
| P/E | — | — |
| P/B | 13.36 | 5.74 |
| P/S | 46.47 | 2940.01 |
| ROE | -41.7% | -7.1% |
| Net Margin | -145.2% | -3629.2% |
| Gross Margin | — | — |
| Revenue Growth | -39.9% | -71.6% |
| Dividend Yield | — | — |
| EPS | -$7.07 | -$0.42 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.